129.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Neurocrine Biosciences Inc Azioni (NBIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
1.33%
805.50
|
794.90 | 687.50 | 572.60 | 622.10 |
| Cost Of Revenue |
25.71%
17.60
|
14.00 | 11.30 | 9.20 | 8.00 |
| Gross Profit |
0.90%
787.90
|
780.90 | 676.20 | 563.40 | 614.10 |
|
|
6.48%
577.00
|
541.90 | 530.60 | 539.80 | 430.30 |
| Benefits Costs and Expenses |
12.52%
566.10
|
503.10 | 528.00 | 557.90 | 431.80 |
| Costs And Expenses |
6.96%
594.60
|
555.90 | 541.90 | 549.00 | 438.30 |
| Operating Income/Loss |
11.76%
210.90
|
239.00 | 145.60 | 23.60 | 183.80 |
| Nonoperating Income/Loss |
46.02%
28.50
|
52.80 | 13.90 | -8.90 | 6.50 |
| Income/Loss From Continuing Operations Before Tax |
17.96%
239.40
|
291.80 | 159.50 | 14.70 | 190.30 |
| Income Tax Expense/Benefit |
4.13%
85.70
|
82.30 | 52.00 | 6.80 | 60.50 |
| Income/Loss From Continuing Operations After Tax |
26.63%
153.70
|
209.50 | 107.50 | 7.90 | 129.80 |
|
|
26.63%
153.70
|
209.50 | 107.50 | 7.90 | 129.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.80%
0.20
|
99.40 | 99.00 | 99.70 | 101.10 |
| Diluted Average Shares |
99.51%
0.50
|
102.50 | 101.00 | 102.50 | 104.30 |
| Basic Earnings Per Share |
27.01%
1.54
|
2.11 | 1.09 | 0.08 | 1.28 |
| Diluted Earnings Per Share |
27.45%
1.48
|
2.04 | 1.06 | 0.08 | 1.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):